93/12 Pill - yellow oval, 10mm

Pill with imprint 93/12 is Yellow, Oval and has been identified as Pantoprazole Sodium Delayed-Release 40 mg. It is supplied by Teva Pharmaceuticals USA.

Pantoprazole is used in the treatment of Barrett's Esophagus; Erosive Esophagitis; Duodenal Ulcer; GERD; Gastritis/Duodenitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93/12

Pantoprazole sodium delayed-release 40 mg 93/12 Front

Pantoprazole sodium delayed-release 40 mg 93/12 Back

Pantoprazole sodium delayed-release 40 mg 93/12

Pantoprazole Sodium Delayed-Release

Imprint: 93/12
Strength: 40 mg
Color: Yellow
Size: 10.00 mm
Shape: Oval
Availability: Prescription only
Drug Class: Proton pump inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: Teva Pharmaceuticals USA
Inactive Ingredients: calcium carbonate, calcium stearate, D&C Yellow No. 10, FD&C Yellow No. 6, hypromellose 2910 (15 mPa.s), ferrosoferric oxide, ferric oxide yellow, lactose monohydrate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, microcrystalline cellulose, polyethylene glycol 4000, propylene glycol, shellac, sodium carbonate, stearic acid, magnesium silicate, titanium dioxide, triethyl citrate
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00093-0012 (Discontinued)	Teva Pharmaceuticals USA, Inc.
42291-0659 (Discontinued)	AvKare, Inc.
54868-5846 (Discontinued)	Physicians Total Care Inc. (repackager)
68071-0782	Nucare Pharmaceuticals Inc. (repackager)